Search research articles
Contact Us
Filters
Showing results (41-50 of 409) with videos related to
Page
of 41
Sort By:
Journal of Clinical Microbiology
|
January 1, 2016
A Word of Caution in Considering the Use of the Lipoarabinomannan Lateral Flow Assay on Cerebrospinal Fluid for Detection of Tuberculous Meningitis
Nathan C Bahr, Lillian Tugume, David R Boulware
The Lancet. Infectious Diseases
|
October 14, 2015
1,3-β-D-glucan in cryptococcal meningitis
Joshua Rhein, David R Boulware, Nathan C Bahr
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 25, 2025
Cryptococcal Meningitis Treatment Beyond HIV: Recognizing the need for Individualized Immune-Based Strategies
Hyunah Yoon, Liise-Anne Pirofski, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 4, 2020
Reply to Neves
Melanie R Nicol, David R Boulware, Radha Rajasingham
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 16, 2025
Revisiting Immune-Mediated Mechanisms as Drivers of Cryptococcal Immune Reconstitution Inflammatory Syndrome
Hyunah Yoon, Liise-Anne Pirofski, David R Boulware
JAMA Network Open
|
January 21, 2026
Is It Time to Use Single-Dose Amphotericin B for HIV-Related Cryptococcal Meningitis?
Nathan C Bahr, Radha Rajasingham, David R Boulware
Expert Review of Anti-Infective Therapy
|
January 24, 2017
Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings
Sarah Lofgren, Mahsa Abassi, Joshua Rhein, et al.
The New England Journal of Medicine
|
July 1, 2008
Hypereosinophilic syndrome and mepolizumab
David R Boulware, William M Stauffer, Patricia F Walker
The New England Journal of Medicine
|
December 14, 2022
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply
Carolyn T Bramante, John B Buse, David R Boulware
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 14, 2013
Accuracy of pima point-of-care CD4 analyzer in routine use in public health clinics in Uganda
Bozena M Morawski, David B Meya, David R Boulware
Page
of 41
Search research articles
Search
Showing results (41-50 of 409) with videos related to
Sort By:
Page
of 41
Journal of Clinical Microbiology
|
January 1, 2016
A Word of Caution in Considering the Use of the Lipoarabinomannan Lateral Flow Assay on Cerebrospinal Fluid for Detection of Tuberculous Meningitis
Nathan C Bahr, Lillian Tugume, David R Boulware
The Lancet. Infectious Diseases
|
October 14, 2015
1,3-β-D-glucan in cryptococcal meningitis
Joshua Rhein, David R Boulware, Nathan C Bahr
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 25, 2025
Cryptococcal Meningitis Treatment Beyond HIV: Recognizing the need for Individualized Immune-Based Strategies
Hyunah Yoon, Liise-Anne Pirofski, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 4, 2020
Reply to Neves
Melanie R Nicol, David R Boulware, Radha Rajasingham
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 16, 2025
Revisiting Immune-Mediated Mechanisms as Drivers of Cryptococcal Immune Reconstitution Inflammatory Syndrome
Hyunah Yoon, Liise-Anne Pirofski, David R Boulware
JAMA Network Open
|
January 21, 2026
Is It Time to Use Single-Dose Amphotericin B for HIV-Related Cryptococcal Meningitis?
Nathan C Bahr, Radha Rajasingham, David R Boulware
Expert Review of Anti-Infective Therapy
|
January 24, 2017
Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings
Sarah Lofgren, Mahsa Abassi, Joshua Rhein, et al.
The New England Journal of Medicine
|
July 1, 2008
Hypereosinophilic syndrome and mepolizumab
David R Boulware, William M Stauffer, Patricia F Walker
The New England Journal of Medicine
|
December 14, 2022
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply
Carolyn T Bramante, John B Buse, David R Boulware
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 14, 2013
Accuracy of pima point-of-care CD4 analyzer in routine use in public health clinics in Uganda
Bozena M Morawski, David B Meya, David R Boulware
Page
of 41